Objective: To construct a risk prediction model for cognitive frailty in patients with chronic kidney disease (CKD) and draw a nomogram, so as to provide a reference for clinical medical staff to predict the risk of cognitive frailty in these patients and take targeted nursing measures. Methods: In this study, patients with CKD in stages 1–3 were collected as a modeling set from October 2022 to April 2023 in the Nephrology Department of two hospitals in Shanghai. Through univariate analysis and multivariate logistic regression analysis, the risk factors of cognitive frailty in patients with CKD in stages 1–3 were screened out, and the risk prediction model was constructed according to the weight of risk factors, and the nomogram was drawn using Stata15.0 software. Bootstrap self-sampling method is used to repeat sampling 1,000 times to verify the built prediction model internally. According to the same inclusion and exclusion criteria, from October 2022 to April 2023, the patient case data of stages 1–3 CKD in the Nephrology Department, a cooperative hospital in Jiangsu Province, were selected as the verification set, and the model was externally verified. Results: In the modeling set (n = 600), cognitive frailty incidence was 38.8% (n = 233), and in the verification set (n = 200), it was 42.0% (n = 84). Independent risk factors include chronic disease count, depression, sleep quality, C-reactive protein, D-dimer, and parathyroid hormone in CKD patients. Internal test showed corrected C-statistic 0.779 (95% CI 0.742–0.816, P < 0.01), Hosmer–Lemeshow χ2 = 5.794, P = 0.670 > 0.05. DCA indicated the model provides positive benefits for intervention decisions. External verification yielded C-statistic 0.909 (95% CI 0.870–0.948, P < 0.01), Hosmer–Lemeshow χ2 = 3.423, P = 0.904 > 0.05. Conclusion: The incidence of cognitive frailty in patients with CKD is high. Patients with CKD with a large number of chronic diseases, severe depressive symptoms, poor sleep quality, abnormal C-reactive protein, abnormal D-dimer, and abnormal parathyroid hormone have a higher risk of cognitive frailty. The risk prediction model has good prediction efficiency, which can provide a reference for clinical medical staff to predict the risk of cognitive frailty in patients with CKD and formulate nursing countermeasures.
Proietti M, Cesari M, 2020, Frailty: What Is It? Adv Exp Med Biol, 1216: 1–7.
Admiraal M, van Zuylen ML, Hermanns H, et al., 2023, The Effect of Preoperative Disability, Cognitive Impairment, Frailty and Opioid Use on Acute Postoperative Pain in Older Patients Undergoing Surgery A Prospective Cohort Study. J Pain, 24(10): 1886–1895.
Kuo YW, Lee JD, 2022, Association between Oral Frailty and Physical Frailty among Rural Middle-Old Community-Dwelling People with Cognitive Decline in Taiwan: A Cross-Sectional Study. Int J Environ Res Public Health, 19(5): 2884.
Ge ML, Chu NM, Simonsick EM, et al., 2023, Order of Onset of Physical Frailty and Cognitive Impairment and Risk of Repeated Falls in Community-Dwelling Older Adults. J Am Med Dir Assoc, 24(4): 482–488.
Li R, Liu Z, Huang R, et al., 2023, Frailty Trajectory Predicts Subsequent Cognitive Decline: A 26-Year Population-Based Longitudinal Cohort Study. MedComm (2020), 4(3): e296.
Anderson BM, Qasim M, Correa G, et al., 2023, Cognitive Impairment, Frailty, and Adverse Outcomes Among Prevalent Hemodialysis Recipients: Results From a Large Prospective Cohort Study in the United Kingdom. Kidney Med, 5(4): 100613.
Paganini-Hill A, Clark LJ, Henderson VW, et al., 2001, Clock Drawing: Analysis in a Retirement Community. J Am Geriatr Soc, 49(7): 941–947.
Chouliara Z, Kearney N, Stott D, et al., 2004, Perceptions of Older People with Cancer of Information, Decision Making and Treatment: A Systematic Review of Selected Literature. Ann Oncol, 15(11): 1596–1602.
Panza F, D’Introno A, Colacicco AM, et al., 2006, Cognitive Frailty: Predementia Syndrome and Vascular Risk Factors. Neurobiol Aging, 27(7): 933–940.
Dartigues JF, Amieva H, 2014, Cognitive Frailty: Rational and Definition from an (I.A.N.A./I.A.G.G.) International Consensus Group. J Nutr Health Aging, 18(1): 95.
Ruan Q, Yu Z, Chen M, et al., 2015, Cognitive Frailty, a Novel Target for the Prevention of Elderly Dependency. Ageing Res Rev, 20: 1–10.
Buckley RF, Villemagne VL, Masters CL, et al., 2016, A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer’s Disease. J Mol Neurosci, 60(3): 354–361.
Verhagen C, Janssen J, Minderhoud CA, et al., 2022, Chronic Kidney Disease and Cognitive Decline in Patients with Type 2 Diabetes at Elevated Cardiovascular Risk. J Diabetes Complications, 36(10): 108303.
Sundstrom J, Bodegard J, Bollmann A, et al., 2022, Prevalence, Outcomes, and Cost of Chronic Kidney Disease in a Contemporary Population of 2.4 Million Patients from 11 Countries: The CaReMe CKD Study. Lancet Reg Health Eur, 20: 100438.
Wang L, Xu X, Zhang M, et al., 2023, Prevalence of Chronic Kidney Disease in China: Results From the Sixth China Chronic Disease and Risk Factor Surveillance. JAMA Intern Med, 183(4): 298–310.
Seo M, Won CW, Kim S, et al., 2020, The Association of Gait Speed and Frontal Lobe among Various Cognitive Domains: The Korean Frailty and Aging Cohort Study (KFACS). J Nutr Health Aging, 24(1): 91–97.
Coppolino G, Bolignano D, Gareri P, et al., 2018, Kidney Function and Cognitive Decline in Frail Elderly: Two Faces of the Same Coin? Int Urol Nephrol, 50(8): 1505–1510.
Mu L, Jiang L, Chen J, et al., 2021, Serum Inflammatory Factors and Oxidative Stress Factors Are Associated With Increased Risk of Frailty and Cognitive Frailty in Patients With Cerebral Small Vessel Disease. Front Neurol, 12: 786277.
Shimada H, Doi T, Lee S, et al., 2018, Cognitive Frailty Predicts Incident Dementia among Community-Dwelling Older People. J Clin Med, 7(9): 250.
Kumar A, Handa R, Upadhyaya SK, et al., 2021, Validation of Hindi Version of the Pittsburg Sleep Quality Index. J Assoc Physicians India, 69(4): 11–12.
Eknoyan G, Levin NW, 2002, Impact of the New K/DOQI Guidelines. Blood Purif, 20(1): 103–108.
Kwan R, Leung A, Yee A, et al., 2019, Cognitive Frailty and Its Association with Nutrition and Depression in Community-Dwelling Older People. J Nutr Health Aging, 23(10): 943–948.
Lee WJ, Peng LN, Liang CK, et al., 2018, Cognitive Frailty Predicting All-Cause Mortality Among Community-Living Older Adults in Taiwan: A 4-Year Nationwide Population-Based Cohort Study. PLoS One, 13(7): e200447.
Ma L, Zhang L, Sun F, et al., 2019, Cognitive Function in Prefrail and Frail Community-Dwelling Older Adults in China. BMC Geriatr, 19(1): 53.
Ma L, Zhang L, Zhang Y, et al., 2017, Cognitive Frailty in China: Results from China Comprehensive Geriatric Assessment Study. Front Med (Lausanne), 4: 174.
McAdams-DeMarco MA, Tan J, Salter ML, et al., 2015, Frailty and Cognitive Function in Incident Hemodialysis Patients. Clin J Am Soc Nephrol, 10(12): 2181–2189.
Chang J, Hou W, Li Y, et al., 2022, Prevalence and Associated Factors of Cognitive Frailty in Older Patients with Chronic Kidney Disease: A Cross-Sectional Study. BMC Geriatr, 22(1): 681.
Luo B, Luo Z, Zhang X, et al., 2022, Status of Cognitive Frailty in Elderly Patients with Chronic Kidney Disease and Construction of a Risk Prediction Model: A Cross-Sectional Study. BMJ Open, 12(12): e60633.
Wang C, Chong Y, Wang L, et al., 2022, The Correlation Between Falls and Cognitive Frailty in Elderly Individuals With Hypertension in a Chinese Community. Front Aging Neurosci, 14: 783461.
Wang C, Zhang J, Hu C, et al., 2021, Prevalence and Risk Factors for Cognitive Frailty in Aging Hypertensive Patients in China. Brain Sci, 11(8): 1018.
Cheng Z, He D, Li J, et al., 2022, C-Reactive Protein and White Blood Cell Are Associated with Frailty Progression: A Longitudinal Study. Immun Ageing, 19(1): 29.
Ribeiro E, Sangali TD, Clausell NO, et al., 2022, C-Reactive Protein and Frailty in Heart Failure. Am J Cardiol, 166: 65–71.
McKechnie D, Patel M, Papacosta AO, et al., 2022, Associations between Inflammation, Coagulation, Cardiac Strain and Injury, and Subclinical Vascular Disease with Frailty in Older Men: A Cross-Sectional Study. BMC Geriatr, 22(1): 405.
von Kanel R, Pazhenkottil AP, Meister-Langraf RE, et al., 2021, Longitudinal Association Between Cognitive Depressive Symptoms and D-Dimer Levels in Patients Following Acute Myocardial Infarction. Clin Cardiol, 44(9): 1316–1325.
Wang Y, Xin Y, Zhao T, et al., 2023, PTH Levels, Sleep Quality, and Cognitive Function in Primary Hyperparathyroidism. Endocrine, 81(2): 379–387.
Chandran M, Yeh L, de Jong MC, et al., 2022, Cognitive Deficits in Primary Hyperparathyroidism - What We Know and What We Do Not Know: A Narrative Review. Rev Endocr Metab Disord, 23(5): 1079–1087.
Murthy L, Dreyer P, Suriyaarachchi P, et al., 2018, Association between High Levels of Parathyroid Hormone and Frailty: The Nepean Osteoporosis and Frailty (NOF) Study. J Frailty Aging, 7(4): 253–257.
Zhu N, Virtanen S, Xu H, et al., 2023, Association between Incident Depression and Clinical Outcomes in Patients with Chronic Kidney Disease. Clin Kidney J, 16(11): 2243–2253.
Lee JK, Won MH, Son YJ, 2018, Combined Influence of Depression and Physical Frailty on Cognitive Impairment in Patients with Heart Failure. Int J Environ Res Public Health, 16(1): 66.
Li C, Zhu Y, Ma Y, et al., 2022, Association of Cumulative Blood Pressure With Cognitive Decline, Dementia, and Mortality. J Am Coll Cardiol, 79(14): 1321–1335.
Olanrewaju O, Stockwell S, Stubbs B, et al., 2020, Sedentary Behaviours, Cognitive Function, and Possible Mechanisms in Older Adults: A Systematic Review. Aging Clin Exp Res, 32(6): 969–984.
Karasavvidou D, Boutouyrie P, Kalaitzidis R, et al., 2018, Arterial Damage and Cognitive Decline in Chronic Kidney Disease Patients. J Clin Hypertens (Greenwich), 20(9): 1276–1284.
Peng S, Chen Y, Li J, et al., 2023, Correlation among Sleep Quality, Physical Frailty and Cognitive Function of the Older Adults in China: The Mediating Role. Front Public Health, 11: 1143033.